-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q1W90gGj5ucWkG7exyLPU1x1b26NXyT5vBZCZ9H4eUJxozdHCRnTQ+ZVJTkXx1cp UTXJVbXiljGGU22HvK5glg== 0001230295-06-000174.txt : 20060705 0001230295-06-000174.hdr.sgml : 20060704 20060705164627 ACCESSION NUMBER: 0001230295-06-000174 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060630 FILED AS OF DATE: 20060705 DATE AS OF CHANGE: 20060705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CONRAD HERBERT J CENTRAL INDEX KEY: 0001218815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 06944839 MAIL ADDRESS: STREET 1: 134 LOWELL RD CITY: GLEN ROCK STATE: NJ ZIP: 07452 4 1 con71.xml X0202 4 2006-06-30 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001218815 CONRAD HERBERT J C/O SAVIENT PHARMACEUTICALS, INC ONE TOWER CENTER BLVD. EAST BRUNSWICK NJ 08816 1 0 0 0 Common Stock, $.01 par value per share 2006-06-30 4 A 0 714 5.2500 A 21419.0000 D Option to Purchase Common Stock, $.01 par value 5.2500 2006-06-30 4 A 0 5000 5.2500 A 2007-06-30 2016-06-30 Common Stock, $.01 par value per share 153150000.0000 5000.0000 D These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $3,750.00, until he is no longer an Outside Director. On June 30, 2006, the fair market value of the Common Stock, based on the closing price, was $5.25. These options will become fully vested and immediately exercisable on 6/30/2007. By: Beata A. Smith as Attorney-In-Fact for 2006-07-05 -----END PRIVACY-ENHANCED MESSAGE-----